Eddy van der Linden
University of Amsterdam
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Eddy van der Linden.
Journal of Molecular Microbiology and Biotechnology | 2005
Tanja Burgdorf; Oliver Lenz; Thorsten Buhrke; Eddy van der Linden; Anne K. Jones; Simon P. J. Albracht; Bärbel Friedrich
Recent research on hydrogenases has been notably motivated by a desire to utilize these remarkable hydrogen oxidation catalysts in biotechnological applications. Progress in the development of such applications is substantially hindered by the oxygen sensitivity of the majority of hydrogenases. This problem tends to inspire the study of organisms such as Ralstonia eutropha H16 that produce oxygen-tolerant [NiFe]-hydrogenases. R. eutropha H16 serves as an excellent model system in that it produces three distinct [NiFe]-hydrogenases that each serve unique physiological roles: a membrane-bound hydrogenase (MBH) coupled to the respiratory chain, a cytoplasmic, soluble hydrogenase (SH) able to generate reducing equivalents by reducing NAD+ at the expense of hydrogen, and a regulatory hydrogenase (RH) which acts in a signal transduction cascade to control hydrogenase gene transcription. This review will present recent results regarding the biosynthesis, regulation, structure, activity, and spectroscopy of these enzymes. This information will be discussed in light of the question how do organisms adapt the prototypical [NiFe]-hydrogenase system to function in the presence of oxygen.
Journal of Bacteriology | 2005
Tanja Burgdorf; Eddy van der Linden; Michael Bernhard; Qing Yuan Yin; Jaap Willem Back; Aloysius F. Hartog; Anton O. Muijsers; Chris G. de Koster; Simon P. J. Albracht; Bärbel Friedrich
The soluble [NiFe]-hydrogenase (SH) of the facultative lithoautotrophic proteobacterium Ralstonia eutropha H16 has up to now been described as a heterotetrameric enzyme. The purified protein consists of two functionally distinct heterodimeric moieties. The HoxHY dimer represents the hydrogenase module, and the HoxFU dimer constitutes an NADH-dehydrogenase. In the bimodular form, the SH mediates reduction of NAD(+) at the expense of H(2). We have purified a new high-molecular-weight form of the SH which contains an additional subunit. This extra subunit was identified as the product of hoxI, a member of the SH gene cluster (hoxFUYHWI). Edman degradation, in combination with protein sequencing of the SH high-molecular-weight complex, established a subunit stoichiometry of HoxFUYHI(2). Cross-linking experiments indicated that the two HoxI subunits are the closest neighbors. The stability of the hexameric SH depended on the pH and the ionic strength of the buffer. The tetrameric form of the SH can be instantaneously activated with small amounts of NADH but not with NADPH. The hexameric form, however, was also activated by adding small amounts of NADPH. This suggests that HoxI provides a binding domain for NADPH. A specific reaction site for NADPH adds to the list of similarities between the SH and mitochondrial NADH:ubiquinone oxidoreductase (Complex I).
Journal of Biological Inorganic Chemistry | 2004
Eddy van der Linden; Tanja Burgdorf; Michael Bernhard; Boris Bleijlevens; Bärbel Friedrich; Simon P. J. Albracht
Infrared spectra of 15N-enriched preparations of the soluble cytoplasmic NAD+-reducing [NiFe]-hydrogenase from Ralstonia eutropha are presented. These spectra, together with chemical analyses, show that the Ni-Fe active site contains four cyanide groups and one carbon monoxide molecule. It is proposed that the active site is a (RS)2(CN)Ni(μ-RS)2Fe(CN)3(CO) centre (R=Cys) and that H2 activation solely takes place on nickel. One of the two FMN groups (FMN-a) in the enzyme can be reversibly released upon reduction of the enzyme. It is now reported that at longer times also one of the cyanide groups, the one proposed to be bound to the nickel atom, could be removed from the enzyme. This process was irreversible and induced the inhibition of the enzyme activity by oxygen; the enzyme remained insensitive to carbon monoxide. The Ni-Fe active site was EPR undetectable under all conditions tested. It is concluded that the Ni-bound cyanide group is responsible for the oxygen insensitivity of the enzyme.
Biochimica et Biophysica Acta | 2003
Simon P. J. Albracht; Eddy van der Linden; Bart W. Faber
Bovine-heart NADH:ubiquinone oxidoreductase (EC 1.6.5.3; Complex I) is the first and most complicated enzyme in the mitochondrial respiratory chain. Biochemistry textbooks and virtually all literature on this enzyme state that it contains one FMN and at least four iron-sulfur clusters. We show here that this statement is incorrect as it is based on erroneous protein determinations. Quantitative amino acid analysis of the bovine Complex I, to our knowledge the first reported thus far, shows that the routine protein-determination methods used for the bovine Complex I overestimate its protein content by up to twofold. The FMN content of the preparations was determined to be at least 1.3-1.4 mol FMN/mol Complex I. The spin concentration of the electron paramagnetic resonance (EPR) signal ascribed to iron-sulfur cluster N2 was determined and accounted for 1.3-1.6 clusters per molecule of Complex I. These results experimentally confirm the hypothesis [FEBS Lett. 485 (2000) 1] that the bovine Complex I contains two FMN groups and two clusters N2. Also the protein content of preparations of the soluble NAD(+)-reducing [NiFe]-hydrogenase (EC 1.12.1.2) from Ralstonia eutropha, which shows clear evolutionary relationships with Complex I, scores too high by the colorimetric protein-determination methods. Determination of the FMN content and the spin concentration of the EPR signal of the [2Fe-2S] cluster shows that this hydrogenase also contains two FMN groups. A third enzyme (Ech), the membrane-bound [NiFe]-hydrogenase from Methanosarcina barkeri which shows an even stronger evolutionary relationship with Complex I, behaves rather normal in protein determinations and contains no detectable acid-extractable FMN in purified preparations.
Journal of Biological Chemistry | 2004
Boris Bleijlevens; Thorsten Buhrke; Eddy van der Linden; Baerbel Friedrich; Simon P. J. Albracht
Journal of the American Chemical Society | 2005
Tanja Burgdorf; Simone Löscher; Peter Liebisch; Eddy van der Linden; Marcus Galander; Friedhelm Lendzian; Wolfram Meyer-Klaucke; Simon P. J. Albracht; Bärbel Friedrich; Holger Dau; Michael Haumann
FEBS Journal | 2004
Eddy van der Linden; Bart W. Faber; Boris Bleijlevens; Tanja Burgdorf; Michael Bernhard; Bärbel Friedrich; Simon P. J. Albracht
Journal of Biological Inorganic Chemistry | 2006
Eddy van der Linden; Tanja Burgdorf; Antonio L. De Lacey; Thorsten Buhrke; Marcel Scholte; Victor M. Fernandez; Bärbel Friedrich; Simon P. J. Albracht
Journal of Physical Chemistry A | 2005
Tanja Burgdorf; Eddy van der Linden; Michael Bernhard; Qing Yuan Yin; Jaap Willem Back; Aloysius F. Hartog; Anton O. Muijsers; Koster de C. G; Simon P. J. Albracht; Bärbel Friedrich
Journal of Molecular Microbiology and Biotechnology | 2005
Irini Vgenopoulou; Melina Haupt; Marc Bramkamp; Antonio J. Pierik; Horst Kessler; Julia Steuber; Dirk Flemming; Stefan Stolpe; Daniel Schneider; Petra Hellwig; Thorsten Friedrich; Murray Coles; Matthias Boll; Reinhard Krämer; Walter G. Zumft; Volker Müller; Karlheinz Altendorf; Reiner Hedderich; Lucia Forzi; Susanne Morbach; Tanja Burgdorf; Oliver Lenz; Thorsten Buhrke; Eddy van der Linden; Anne K. Jones; Simon P. J. Albracht; Bärbel Friedrich; T. Lemker; A. Lingl; C. Weidner